Hear2Care
Tingting Zhang PhD currently leads the TACTIC Initiative
EGFRResisters
Jill Feldman Co-Founder
Advocates for Collaborative Education
Stacey Tinianov Executive Director
Patient Centered Dosing Initiative
METAvivor
Janice Cowden
Lobular Breast Cancer Alliance
Gitte H Joergensen PhD
Inflammatory Breast Cancer Research Foundation
Ginny Mason Executive Director
Advocates for Universal DPD/DPYD Testing
Karen Merritt
Patient Advocates at SWOG
TBD
Independent Advocates
Sarah M Greene
JJ Singleton: “I’m long-term survivor of early-onset stage 4 terminal colorectal cancer. Diagnosed in September 2015 at the age of 27, I’ve spent over a decade navigating treatments 190 and counting while dedicating my life to cancer advocacy, breaking down stigma for young men, and reshaping clinical trial transparency as well as advocating for colorectal cancer and rural healthcare and oncology.”
Anna Hedden
IN MEMORIAM
Amy Buemer PhD “Amy was diagnosed with Stage I breast cancer as well as extensive ductal carcinoma in situ (DCIS) in 2017, at the age of 38, a newly married assistant professor with a PhD in microbiology… Her work spanned legislative advocacy, peer support and mentoring, research, and education… Amy was also a trained peer support group leader and patient advocate grant reviewer for METAvivor, eventually becoming a member of its Board of Directors… She was also a team member supporting the Patient Centered Dosing Initiative, working to educate healthcare professionals and patients on the benefits of partnering to determine a personalized dose of cancer drugs with the aim of easing severe side effects, and allowing patients to stay on treatments longer while maintaining effectiveness.” -MBC Alliance JUNE 12, 2026
Reagan-Udall Foundation for the FDA
Carla V Rodriguez PhD leads the UPLIFT “Understanding the Patient’s Landscape In the Face of Treatment toxicities” effort
Multinational Association of Supportive Care in Cancer (MASCC)
Maryam Lustberg MD served as President of MASCC between 2022 and 2024.
Hope Rugo MD Leads MASCC Emerging Toxicities Study Group
American Socitiesy of Clinical Oncology (ASCO)
Eric Roeland MD leads ASCO ASPirE “Alliance for Support and Prevention of Immune-Related Adverse Events”
Tony KW Hung MD
Rutikan Mehta MD
Joanna Metzner-Sadurski MD is a member of ASCO Health Policy Committee
Oncology Nursing Society
Darcy Burbage
The Health and Environmental Sciences Institute (HESI)
Syril Pettit D. PH Executive Director